Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

Merck Sharp & Dohme Corp has been awarded a state contract (HHSTX-6-0000390762) by Texas for the procurement of childhood vaccines. The contract references the current Centers for Disease Control and Prevention (CDC) Federal Contract for Vaccine and Biologicals, specifically CDC Federal Contract Number 75D30125D00195. The awarded vaccines encompass multiple UNSPSC categories including diphtheria and tetanus toxoids, rubella virus vaccine, tetanus vaccine, and other medical agents, classified under the NIGP code 26980 for Serums, Toxoids, and Vaccines.

The contract, dated November 26, 2025, appears to be structured to enable the state of Texas to access vaccine pricing through the referenced CDC federal contract. While specific contract value details are not provided, the award suggests a comprehensive vaccination procurement arrangement. The contract covers multiple vaccine types critical for childhood immunization programs, with Merck serving as the prime contractor and vaccine manufacturer, leveraging its established federal contract pricing mechanism to provide vaccines to the state of Texas.